Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;94(3):1212-1216.
doi: 10.1002/jmv.27392. Epub 2021 Oct 19.

Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19

Katia Lino  1   2 , Lilian S Alves  1   3 , Jessica V Raposo  4 , Thalia Medeiros  1   3 , Cintia F Souza  1   2 , Andrea A da Silva  1   5   3 , Vanessa S de Paula  4 , Jorge R Almeida  1   6   2
Affiliations

Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19

Katia Lino et al. J Med Virol. 2022 Mar.

Abstract

Human herpesvirus-6 (HHV-6) may cause serious diseases in immunocompromised individuals. SARS-CoV-2/HHV-6 coinfection has been emphasized in previous works, mostly case reports, small series, or epidemiological studies, but few are known about its real clinical outcomes. Here we present a real-world pilot study aiming to understand the frequency and the clinical impact of HHV-6 coinfection in moderate to critically ill patients hospitalized due to COVID-19. SARS-CoV-2 and HHV-6 were evaluated in nasopharyngeal samples at the hospital admission of suspected COVID-19 patients. From 173 consecutive cases, 60 were SARS-CoV-2 positive and 13/60 (21.7%) were HHV-6 positive after identified as the HHV-6B species by a Sanger sequencing. The SARS-CoV-2+/HHV-6+ group was younger but not significant for cardiovascular diseases, diabetes, obesity, and cancer, but significant among therapeutic immunosuppressed patients (as systemic lupus erythematosus and kidney transplant patients). In the medical records, only sparse data on cutaneous or neurological manifestations were found. Biochemical and hematological data showed only a trend towards hyperferritinemic status and lymphopenia. In conclusion, despite the impressive high frequency of HHV-6 coinfection in SARS-CoV-2 positive cases, it did not impact general mortality. We suggest larger future prospective studies to better elucidate the influence of HHV-6 reactivation in cases of COVID-19, designed to specific assessment of clinical outcomes and viral reactivation mechanisms.

Keywords: COVID-19; HHV-6; herpesvirus-6.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zanella MC, Cordey S, Kaiser L. Beyond cytomegalovirus and Epstein‐Barr virus: a review of viruses composing the blood virome of solid organ transplant and hematopoietic stem cell transplant recipients. Clin Microbiol Rev. 2020;33(4). - PMC - PubMed
    1. Sehrawat S, Kumar D, Rouse BT. Herpesviruses: harmonious pathogens bute. relevant cofactors in other diseases? Front Cell Infect Microbiol. 2018;8:177. - PMC - PubMed
    1. Agut H, Bonnafous P, Gautheret‐Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev. 2015;28(2):313‐335. - PMC - PubMed
    1. Raposo JV, Sarmento D, Pinto R, et al. Longitudinal study on oral shedding of human betaherpesviruses 6 and 7 in renal transplant recipients reveals active replication. J Oral Microbiol. 2020;12(1):1785801. - PMC - PubMed
    1. Kawano Y, Kawada JI, Nagai N, Ito Y. Reactivation of human herpesviruses 6 and 7 in Kawasaki disease. Mod Rheumatol. 2019;29(4):651‐655. - PubMed

Publication types